Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough
A Randomized, Double-blind, Placebo-controlled, Dose-escalation Study Evaluating the Efficacy of Two Doses of Duloxetine & Amitriptyline in Subjects With Refractory Chronic Cough
Mayo Clinic
50 participants
Nov 1, 2021
INTERVENTIONAL
Conditions
Summary
This research study is evaluating the effectiveness of escalating doses of Amitriptyline and Duloxetine in reducing cough frequency in patients with refractory chronic cough (RCC)
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
30mg orally for 4 weeks
60mg orally for 4 weeks
25 mg orally for 4 weeks
50 mg orally for 4 weeks
30mg tablet with no active study ingredient for 4 weeks
60mg tablet with no active study ingredient for 4 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05110144